These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 8579186

  • 1. Evaluation of mastoid obliteration surgery.
    Minatogawa T, Machizuka H, Kumoi T.
    Am J Otol; 1995 Jan; 16(1):99-103. PubMed ID: 8579186
    [Abstract] [Full Text] [Related]

  • 2. Obliteration of the persistently discharging mastoid cavity using the middle temporal artery flap.
    Singh V, Atlas M.
    Otolaryngol Head Neck Surg; 2007 Sep; 137(3):433-8. PubMed ID: 17765771
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mastoid cavity obliteration: our experience.
    Deshmukh S, Sharma A, Dabholkar J.
    Otolaryngol Pol; 2012 Sep; 66(6):379-81. PubMed ID: 23200556
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fascioperiosteal flap and neo-osteogenesis in radical mastoidectomy: long-term results.
    Kahramanyol M, Ozünlü A, Pabusçu Y.
    Ear Nose Throat J; 2000 Jul; 79(7):524-6. PubMed ID: 10935305
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mastoid obliteration with postconchal soft tissue and postauricular pericranial flap.
    Tantinikorn W, Assanasen P, Prakairungthong S.
    J Med Assoc Thai; 2012 Oct; 95(10):1306-11. PubMed ID: 23193745
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Bioactive glass obliteration of the mastoid significantly improves surgical outcome in non-cholesteatomatous chronic otitis media patients.
    Vos J, de Vey Mestdagh P, Colnot D, Borggreven P, Orelio C, Quak J.
    Eur Arch Otorhinolaryngol; 2017 Dec; 274(12):4121-4126. PubMed ID: 28956143
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Canal-down tympanoplasty; one-stage tympanoplasty with mastoid obliteration, for non-cholesteatomatous chronic otitis media associated with osteitis.
    Shinkawa A, Sakai M, Tamura Y, Takahashi H, Ishida K.
    Tokai J Exp Clin Med; 1998 Mar; 23(1):19-23. PubMed ID: 9972532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.